Sarcomen Team 3
123

Sarcomas and GIST Center

Welcome to the NKI Sarcomas and GIST center at the Netherlands Cancer Institute. We specialize in the treatment of sarcomas and gastrointestinal stromal tumors (GIST), malignant tumors that originate in soft tissue or bones. That’s why these rare tumors are also known as soft tissue tumors. At the NKI Sarcoma and GIST Center, we have a team of expert physicians, nurses, and specialist available to help guide you through the process of treating these rare conditions. At our center, you will receive the best care possible.

The specialists at our clinic are familiar with sarcomas throughout the entire body. They have years of experience and expertise with sarcomas and GIST. That’s why you can be sure that the Netherlands Cacer Institute is the right hospital for you. Our specialists see the most sarcoma patients in the Netherlands every year, so you can be sure that we remain at the forefront of the latest research and treatment of the disease.

At the NKI, you will receive the most optimized and personalized treatment that is currently available for you. We understand that you and your loved ones are facing a difficult time in your lives, and you are not alone. 

Read more about the symptoms and treatment

Why the NKI Sarcomas and GIST Center?

Because soft tissue tumors are so rare and varied in their location, behavior, and sensitivity to treatment, the past couple of years have shown us how important it is to refer these sarcoma patients to an expert center for soft tissue tumors like the Netherlands Cancer Institute. Especially patients with high-risk sarcomas are proven to have a better quality of life after their treatment when treated at an expert center. 

  • Have you been diagnosed with breast cancer at a different hospital? You can come to us for a second opinion and/or treatment. 
  • Research and care in one location: you can be sure that you will be treated according to the latest developments. We can give you a personalized treatment plan.
  • GIST is a rare illness that calls for a multidisciplinary team, assessment, and treatment advice. This is why the pathologist, radiologist, surgeon, and medical oncologist at the NKI collaborate together. The multidisciplinary sarcoma team has a lot of experience in treating GIST.
  • Large focus on supportive care, like physical therapy, mental health care, dietetics, and rehabilitation.
  • Plenty of time for you and your loved ones.
  • 1590

    patients with sarcomas
  • 445

    new patients
  • 27

    second opinions

Read more about making an appointment and second opinion

7 days

rapid diagnostics

Every Tuesday we schedule a clinic for new patients coming in for rapid diagnostics or second opinions. The wait times will depend on the day of referral, but new patients can usually come to the clinic on the following Tuesday.

Your sarcoma treatment team

Our specialists excel at sarcomas/soft tissue tumors and GIST. They come together for a multidisciplinary team meeting during which they will review your test results and medical history in order to find the best treatment plan for you. Your physician will discuss this plan with you. At the Netherlands Cancer Institute you are an equal partner in our team, and we will decide on your treatment together. 

Treatment team GIST

8.8

Patient satisfaction rates at the Netherlands Cancer Institute

Patients give the Netherlands Cancer Institute the following ratings.

  • 9.1
    Expertise
  • 8.9
    Listen
  • 9.0
    Explanation
  • 8.7
    Wishes when choosing treatment
  • 8.8
    Shared decision making

Trials

Next to its clinical work, the Netherlands Cancer Institute is a distinguished cancer research institute. 700 enthusiastic researchers work hard every day to gain a better understanding of the development and treatment of cancer. Many of our trials concern sarcomas or GIST. If we find a trial that is suitable for you, your practicing physician will discuss this with you.

Several sarcoma trials

This website uses cookies

We use cookies on our website to improve the user experience.